SSR504734 HCl

Name: SSR504734 HCl
Brand: TargetMol
SKU: T90597
Price: 619 CNY
Availability: InStock
Rating: 5 (10 reviews)

很棒

产品编号 T90597Cas号 615571-23-8

SSR504734 是一种具有口服活性、选择性和可逆性的 GlyT1抑制剂 (hGlyT1，rGlyT1，mGlyT1IC50分别为 18、15 和 38 nM)。SSR504734 在精神分裂症、焦虑症和抑郁症模型中表现出活性。

为众多的药物研发团队赋能，

让新药发现更简单！

SSR504734 HCl

很棒

纯度: 99.54%

产品编号 T90597Cas号 615571-23-8

规格	价格	库存
1 mg	¥ 619	现货
5 mg	¥ 1,230	现货
10 mg	¥ 1,880	现货
25 mg	¥ 3,360	现货
50 mg	¥ 4,930	现货
100 mg	¥ 7,270	现货

大包装 & 定制

加入购物车

该分子属于定制产品。TargetMol拥有优秀的合成团队，经验和能力，可以为您提供高性价比的产品。但由于客观因素，研发中会存在小概率合成不成功的情况，还请理解，如您有任何问题，欢迎咨询，我们将竭诚为您服务。

实验操作小课堂

常见问题解答

选择批次:

纯度:99.54%

联系我们获取更多批次信息

资源下载

COA HPLC HNMR 产品操作手册

产品介绍

生物活性

产品描述	SSR504734 is an orally active, selective and reversible inhibitor of human, rat, and mouse GlyT1 ( IC 50 =18, 15, and 38 nM, respectively). SSR504734 exhibits activity in schizophrenia, anxiety and depression models [1].
体外活性	SSR504734 (15 nM-86 μM; 10 min) inhibits the ex vivo uptake of glycine in human SK-N-MC and rat C6 cells [1]. Cell Viability Assay [1] Cell Line: Human neuroblastoma (SK-N-MC) and rat astrocytoma (C6) cells Concentration: 15 nM-86 μM Incubation Time: 10 min Result: Showed IC 50 values of 18 and 15 nM for human SK-N-MC and rat C6 cells, respectively.
体内活性	SSR504734 (i.p. and p.o.; 1-100 mg/kg; once) treatment demonstrates good oral bioavailability [1]. SSR504734 (i.p.; 30 mg/kg; once) induces a rapid and significant decrease of specific glycine uptake [1]. SSR504734 (i.p.; 10 mg/kg; once) increases extracellular levels of Glycine in the prefrontal cortex (PFC) of freely moving rats [1]. Animal Model: Male Sprague-Dawley rats [1] Dosage: 1-100 mg/kg Administration: Intraperitoneal injection and oral gavage.; 1-100 mg/kg; once Result: Showed ID 50 values of 5.0 and 4.6 mg/kg for i.p. and p.o. treatments, respectively. Animal Model: Male Sprague-Dawley rats [1] Dosage: 30 mg/kg Administration: Intraperitoneal injection; 30 mg/kg; once Result: Maintained at about 80% inhibition from 1 to 7 h after administration. Animal Model: Male Sprague-Dawley rats [1] Dosage: 10 mg/kg Administration: Intraperitoneal injection; 10 mg/kg; once Result: Produced a rapid and sustained increase in PFC extracellular levels of glycine.